Image 1_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Image 2_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Image 5_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Image 6_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Image 3_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Image 4_Esophageal cancer mortality trends in the United States: a comprehensive longitudinal study (1999–2023) using CDC WONDER data.tif حسب Xuefei Yang (2300221)

"…Geographically, mortality trends diverged: metropolitan areas experienced a significant decline (AAPC: −1.09*), whereas non-metropolitan areas experienced a significant increase (AAPC: 0.48*). …"

Uptake of the intervention (N = 49). حسب Stanley Carries (21172287)

الموضوعات:

Baseline characteristics of sample by trial arm. حسب Stanley Carries (21172287)

الموضوعات:

CweL trial design. حسب Stanley Carries (21172287)

الموضوعات:

Participant Flow. حسب Stanley Carries (21172287)

الموضوعات:

Economic cost composition by arm and outcomes. حسب Stanley Carries (21172287)

الموضوعات:

Concurrent mixed methods design diagram. حسب Esario IV Daguman (21474116)

الموضوعات:

The guiding map. حسب Esario IV Daguman (21474116)

الموضوعات:

Supplementary file 1_Association between changes in corrected anion gap and mortality among critically ill patients during ICU stay: a multicenter observational study.doc حسب Yanli Hou (6561536)

"…When analyzed categorically, the ΔcAG still exhibited a significant risk gradient across quartiles.</p>Conclusion<p>Further elevated cAG after ICU admission demonstrates a robust association with an increased mortality risk in critically ill patients. …"

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. حسب William C. Barley (8915282)

الموضوعات:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). حسب William C. Barley (8915282)

الموضوعات:

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... حسب figshare admin karger (2628495)

Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022. حسب Myriam Aïche (22290591)

الموضوعات:

The properties of dental materials: Purpose of usage, manufacturer, composition, setting type and setting time. حسب Meltem Karahan (19713246)

الموضوعات:

Association between platelet count and height loss by hypertension status. حسب Yuji Shimizu (174369)

الموضوعات: